Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group (Q77873031)
Jump to navigation
Jump to search
scientific article published on 01 June 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group |
scientific article published on 01 June 1999 |
Statements
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group (English)
Barrett-Connor E
Hochberg MC
Ross PD
Black D
Cummings SR
Genant HK
Nevitt MC
Musliner T